GL1X · GenesisL1 explorer

MolNFT v1 · #106808 · protein

Human transthyretin (ttr) complexed with (R)-3-(9H-fluoren-9- ylideneaminooxy)-2-methyl-N-(methylsulfonyl) propionamide in a dual binding mode

4TQP: “Human transthyretin (ttr) complexed with (R)-3-(9H-fluoren-9- ylideneaminooxy)-2-methyl-N-(methylsulfonyl)…”. X-ray diffraction, 1 ligand (48R), 2 pockets (best druggability 0.35). MolNFT v1 #106808 on GenesisL1: 3D structure…

PDB
4TQP
Type
protein
Length
232 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
48R
Pockets
2 · best druggability 0.35

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1166% helix, 51% strandP02766

Ligands and binding sites

  • 48R · (2R)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methyl-N-(methylsulfonyl)propanamide · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1750.350.7615empty
2610.310.7514GOL

Interfaces

1 interface between chains.

  • A–B · 944 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 4TQP · Human transthyretin (TTR) complexed with (R)-3-(9H-fluoren-9-ylideneaminooxy)-2-methyl-N-(… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.